Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Biomater Appl ; 28(6): 869-79, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23594681

RESUMO

Traumatic injury is the leading cause of death in people aged 44 or less in the US. It is also estimated that 82% of deaths from battlefield hemorrhage may be survivable with better treatment options. In this study, two biomaterial hemostats having disparate mechanisms were evaluated in a large animal lethal hemorrhage model and compared to a commercial product and standard cotton gauze. We hypothesized that the biomaterial with a biologically active mechanism, as opposed to a mechanical mechanism, would be the most effective in this model. Using a published study protocol, the femoral artery in swine was punctured and treated. KeraStat™ (KeraNetics) and Nanosan®-Sorb (SNS Nano) hemostats were compared to a commercial chitosan dressing (second generation Hemcon®) and cotton gauze. Both KeraStat and Nanosan increased survival, significantly increased mean arterial pressure (MAP), and significantly decreased shock index compared to both controls. The Hemcon dressing was no different than gauze. Platelet adhesion assays suggested that the KeraStat mechanism of action involves ß1 integrin mediated platelet adhesion while Nanosan-Sorb operates similar to one reported mechanism for Hemcon, absorbing fluid and concentrating clotting components. The Nanosan also swelled considerably and created pressure within the wound site even after direct pressure was removed.


Assuntos
Materiais Biocompatíveis , Modelos Animais de Doenças , Hemorragia/terapia , Hemostasia , Queratinas , Poliuretanos , Animais , Extremidades/irrigação sanguínea , Feminino , Suínos
2.
Acta Biomater ; 9(3): 5431-7, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23178862

RESUMO

Natural extracellular matrix (ECM) proteins possess critical biological characteristics that provide a platform for cellular adhesion and activation of highly regulated signaling pathways. However, ECM-based biomaterials can have several limitations, including poor mechanical properties and risk of immunogenicity. Synthetic biomaterials alleviate the risks associated with natural biomaterials but often lack the robust biological activity necessary to direct cell function beyond initial adhesion. A thorough understanding of receptor-mediated cellular adhesion to the ECM and subsequent signaling activation has facilitated development of techniques that functionalize inert biomaterials to provide a biologically active surface. Here we review a range of approaches used to modify biomaterial surfaces for optimal receptor-mediated cell interactions, as well as provide insights into specific mechanisms of downstream signaling activation. In addition to a brief overview of integrin receptor-mediated cell function, so-called "biomimetic" techniques reviewed here include (i) surface modification of biomaterials with bioadhesive ECM macromolecules or specific binding motifs, (ii) nanoscale patterning of the materials and (iii) the use of "natural-like" biomaterials.


Assuntos
Materiais Biocompatíveis/farmacologia , Biomimética/métodos , Animais , Adesão Celular/efeitos dos fármacos , Proteínas da Matriz Extracelular/metabolismo , Humanos , Nanotecnologia , Transdução de Sinais/efeitos dos fármacos
3.
Biomaterials ; 34(10): 2492-500, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23332318

RESUMO

Uncontrolled bleeding continues to be one of the leading causes of death in individuals following traumatic injury. Prognosis is worsened with the onset of acute coagulopathy characterized by metabolic acidosis, hypothermia and hemodilution, which consequently perpetuates blood loss and increases mortality. While there are several limitations to biomaterials employed as hemostatic agents, keratin biomaterials have demonstrated efficacy in mitigating blood loss in an animal model of hemorrhage in prior studies. Here we investigate the hypothesis that keratins actively participate in coagulation and that a potential mechanism of action is independent of temperature and dilution of clotting factors. Data from this study show that keratins appear to contribute to hemostasis by significantly decreasing plasma clotting lag times and are able to maintain activity under simulated conditions of coagulopathy. Moreover, a system of isolated fibrin polymerization provided evidence of increased fibril lateral assembly in the presence of keratin. The data provided here provides a platform for further development of keratin biomaterials as hemostatic agents.


Assuntos
Materiais Biocompatíveis/farmacologia , Coagulação Sanguínea/efeitos dos fármacos , Hemostasia/efeitos dos fármacos , Queratinas/farmacologia , Materiais Biocompatíveis/química , Células Cultivadas , Humanos , Queratinas/química , Microscopia Eletrônica de Varredura
4.
Biomaterials ; 34(11): 2632-40, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23340195

RESUMO

Driven by new discoveries in stem-cell biology and regenerative medicine, there is broad interest in biomaterials that go beyond basic interactions with cells and tissues to actively direct and sustain cellular behavior. Keratin biomaterials have the potential to achieve these goals but have been inadequately described in terms of composition, structure, and cell-instructive characteristics. In this manuscript we describe and characterize a keratin-based biomaterial, demonstrate self-assembly of cross-linked hydrogels, investigate a cell-specific interaction that is dependent on the hydrogel structure and mediated by specific biomaterial-receptor interactions, and show one potential medical application that relies on receptor binding - the ability to achieve hemostasis in a lethal liver injury model. Keratin biomaterials represent a significant advance in biotechnology as they combine the compatibility of natural materials with the chemical flexibility of synthetic materials. These characteristics allow for a system that can be formulated into several varieties of cell-instructive biomaterials with potential uses in tissue engineering, regenerative medicine, drug and cell delivery, and trauma.


Assuntos
Materiais Biocompatíveis/química , Cabelo/química , Hemostáticos/metabolismo , Hidrogéis/química , Queratinas/química , Animais , Materiais Biocompatíveis/análise , Plaquetas/citologia , Plaquetas/metabolismo , Western Blotting , Adesão Celular , Colorimetria , Eletroforese , Hemostasia , Humanos , Hidrogéis/análise , Queratinas/análise , Espectrometria de Massas , Microscopia Confocal , Microscopia Eletrônica de Varredura , Medicina Regenerativa/métodos , Reologia , Suínos , Engenharia Tecidual/métodos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa